The prospects of pazopanib in advanced renal cell carcinoma
The landscape of treatment for advanced/metastatic renal cell carcinoma (mRCC) has advanced significantly in the last decade and continues to evolve with the approval of new drugs targeting the vascular endothelial growth factor (VEGF) and its receptors and mammalian target of rapamycin (mTOR). Curr...
Na minha lista:
| Principais autores: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publishing
2013-10-01
|
| coleção: | Therapeutic Advances in Urology |
| Acesso em linha: | https://doi.org/10.1177/1756287213495099 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|